Skip to main content
. 2011 Mar 16;5(1):37–45. doi: 10.5009/gnl.2011.5.1.37

Table 2.

Clinical Efficacy of IFX Therapy

graphic file with name gnl-5-37-i002.jpg

Data are presented as mean±SD.

IFX, infliximab; CDAI, Crohn's disease activity index; IBDQ, inflammatory bowel disease questionnaire; WBC, white blood cell count; CRP, C-reactive protein; ALB, albumin.

*p<0.001, p<0.03, and p<0.05 vs pre 1st IFX.